Archive

In our newsletter, you will find the latest news and comments on legal and trade-related developments in various areas of Iranian commercial and financial law and practice.

Contents

List of drugs to be manufactured for downsizing imports Iran Sets Punishment for Errant Exporters Import of Livestock Permitted Accession of Iran to Patent Cooperation Treaty (PCT) Commercial Benefit Dues on Prefab Housing Equipment Reduced to Zero Calculation of Import Dues in Current Year Remains Unchanged Commercial Benefit Rates for Import of SKD and CKD Goods Tax Exemption for Petrochemical Exports Evaluation of Imported Goods Rate parity for foreign and Iranian national hotel guests New Law for Iranian-Greek mutual foreign investment Export of Wheat Allowed Importation Permitted Except from Israel Identity Tags and Codes for Iranian Carpets Non-standard goods shall be returned to sender Anti-dumping decree comes into effect 15 Special Facilities for Investors in Qeshm Free Zone Prosecution for late exit of temporarily-imported vehicles Iran implements law for protecting car owners Bylaw of the Law of the Special Economic Zones Organizational Changes in Registration of Companies and Intellectual Property Foreign Brand Names Restricted to Duly Licensed Manufacturers Minimum Commercial Benefit Tax for S.K.D. and C.K.D. Goods Importation of Motor Vehicles Allowed as Before Commercial Cards Issued in Free Zones Valid on Mainland Penalties for Unauthorized Stay of Foreign Nationals Imported Goods Tariffs of Past Year Applicable to Current Year Invoices for Imported Goods Must be Legalized

26 December 2007

List of drugs to be manufactured for downsizing imports

Nourlaw.com, 26 December 2007 -- The director general for surveillance of drugs and narcotics affairs of the ministry of health in circular letter number D/5/52/39054 dated 7/9/86 (28 November 2007) has declared: 'Since provision of factual and transparent information in relation to adoption of expertly and adequately rendered decisions shall have an important and indisputable role in expansion of the national drug industry, attached hereto is the list of the drugs for which manufacturing licenses are available. It also contains the number of applicants and the stage of consideration for the related files and the drugs for which import applications have been made. It is hoped that the related expertise, experience, technology, time and financial resources shall be utilized to expedite the issuance of licenses for the manufacture of new drugs and result in further reduction of the country's dependence on imported drugs. The list has been placed on the Food and Drug Office website www.fdo.ir and shall be updated every month".   The list is as seen here below.  Rank Code Name of Drug Number of Applications in the Registration Department In Process of Consideration Number of Permits Issued Number of Registered Imported Drug       1 7 ACETAMINOPHEN 325MG TAB 2 4 8     2 2012 ACETAMINOPHEN 500MG TAB 2 4 13     3 1842 ALENDRONATE SODIUM 10MG TAB 1 4 4 1   4 2406 ALENDRONATE SODIUM 70MG TAB 1 3 3 1   5 1382 ALPRAZOLAM 1MG TAB 1 3 4     6 40 ALPRAZOLAM 0.5MG TAB 1 3 5 2   7 49 ALUMINIUM MGS SUSP 1 3 5     8 70 AMLODIPINE BESYLATE 5MG TAB 1 4 18 2   9 78 AMOXICILLIN 250MG/5ML 100ML POW SUSP 1 3 5     10 114 ATENOLOL 100MG TAB 2 4 8     11 1911 ATORVASTATIN 20MG TAB 2 4 19 1   12 1912 ATORVASTATIN 40MG TAB 2 4 13     13 159 BETAMETHASONE 0.1% LOTION 1 3 3     14 160 BETAMETHASONE 0.1% I5G OINT 2 4 8     15 2028 BRIMONIDINE TARTRATE 0.2% OPH DROP 1 1 0 1   16 1414 BUPRENORPHINE 0.3MG/1ML AMP 1 2 1     17 2312 CALCITONIN 100 IU/ML AMP 1 1 0 1   18 206 CAPTOPRIL 50MG TAB 1 3 3     19 2475 CARVEDILOL 6.25MG TAB 4 4 7 2   20 1924 CARVEDILOL 12.5MG TAB 5 4 7 2   21 1925 CARVEDILOL  25MG TAB 5 4 5 1   22 246 CEPHALEXIN 250MG/5ML 100ML POW FOR SUSP 1 4 5     23 2418 CEFEPIME HYDROCHLORIDE 500MG ViAL 2 3 2 1   24 2416 CEFEPIME HYDROCHLORIDE 1 G VIAL 2 3 2 1   25 2417 CEFEPIME HYDROCHLORIDE 2 G VIAL 2 3 2 1   26 7495 CEFIXIME 200MG CAP 1 4 8     226 CEFIXIME 200MG TAB   27 3849 CEFIXIME 100MG/5ML 50ML FOR SUSP 1 4 8     2419 CEFIXIME 100MG/5ML 100ML FOR SUSP   28 1913 CELECOXIB 100MG CAP 1 4 17 2   29 1932 CELECOXIB 200MG CAP 1 3 2 1   30 290 CIMETIDINE 200MG TAB 1 3 4     31 295 CIPROFLOXACIN HCL 250MG TAB 1 4 7     32 296 CIPROFLOXACIN HCL 500MG TAB 2 4 8     33 1905 CITALOPRAM HBR 20MG FC TAB 3 4 14     34 1906 CITALOPRAM HBR 40MG FC TAB 1 4 13     35 2232 CETIRIZINE 2HCL 5MG/5ML 60ML SYRUP 1 3 5     36 1424 CETIRIZINE 2HCI 10MG TAB 1 4 4 2   37 2034 CLARITHROMYCIN 500MG TAB 1 3 4 2   38 314 CLOBETASOL PROPIONATE 0.05% 15G OINT 1 3 4     39 323 CLONAZEPAM 2MG TAB 1 4 6     40 1788 CLOPIDOGREL BISULFATE 75MG TAB 1 3 5 1   41 2230 CLOTRIMAZOLE 2% 20G VAG CREAM 1 4 4     42 1440 CO-AMOXICLAV 312 (250/62.5) POW SUSP 1 3 3     43 339 Co TRIMOXAZOLE 400/80 MG TAB 1 3 6     44 364 CROMOLYN SODIUM 20MG INHAL CAP 1 1 0 1   45 379 DANAZOLE 100MG CAP 1 1 0 1   46 1338 DESMOPRESSIN ACETATE 4MCG/ML AMP 1 1 0 1   47 398 DEXAMETHASONE 0.5MG TAB 1 2 1     48 408 DEXTROMETHORPHAN P 60ML SYRUP 1 4 6     49 1928 DONEPEZIL 10MG TAB 1 3 2 2   50 5964 DORZOLAMIDE+TIMOLOL 2%/0.5% OPH DROP 1 1 0 0   51 456 DIPHENHYDRAMINE COMPOUND 6OML SYRUP 1 4 11     52 2051 FLUOXETINE 2OMG/5ML SYRUP 1 3 2     53 5657 EZETIMIBE 10MG TAB 8 3 7     54 2280 OXCARBAZEPINE 150MG TAB 2 3 2     55 2447 OXCARBAZEPINE 300MG TAB 2 3 2     56 2448 OXCARBAZEPINE 600MG TAB 1 2 1     57 6751 FEXOFENADINE 120MG TAB 1 2 1     58 7251 FEXOFENADINE 60MG TAB 1 3 3     59 1872 FINASTERIDE 1MG TAB 1 3 2     60 535 FINASTERIDE 5MG TAB 1 3 3     61 1827 FLUVOXAMINE MALEATE 50MG TAB 2 4 6     62 572 GABAPENTIN 100MG CAP 1 4 9 1   63 573 GABAPENTIN 300MG CAP 1 4 8 2   64 659 IBUPROFEN 400MG TAB 3 4 11     65 657 IBUPROFEN 100MG/5ML SUSP 2 3 4     66 719 ISOSORBIDE DINITRATE 5MG TAB 1 2 1     67 727 KETOTIFEN FUMARATE 1MG TAB 1 4 10 4   68 728 KETOTIFEN FUMARATE 1MG/5ML 100ML SYRUP 2 4 6 1   69 2441 LEVONORGESTREL 0.75MG TAB 1 2 1     70 773 LOVASTATIN 20MG TAB 2 4 10     71 756 LIDOCAINE HCL 2% GEL 1 2 1     72 753 LIDOCAINE HCL 2% 5ML AMP 2 3 2     73 765 LISINOPRIL 20MG TAB 1 3 4     74 2011 LORATADINE 1MG/ML 60ML SYRUP 2 4 7     75 1574 LORATADINE 10MG TAB 1 4 11     76 1822 LOSARTAN POTASSIUM 25MG TAB 2 4 9     77 817 METFORMIN HCL 500MG TAB 1 4 7 3   78 840 METOCLOPRAMIDE 4MG/ML 15ML ORAL DROP 2 3 3     79 852 MIDAZOLAM HCL 5MG/1ML AMP 1 3 4     80 1829 MINOXIDIL 5%60MLTOP SOL 1 3 5     81 7767 MUPIROCIN 2% 10G OINT 2 3 3     875 MUPIROCIN 2% 15GR OINT   82 889 NAPROXEN 250MG TAB 1 4 13     83 1606 NAPROXEN 500MG TAB 2 4 8     84 905 NIMODIPINE 30MG TAB 1 1 0 1   85 904 NIMODIPINE 10MG/5OML INF 1 1 0 1   86 930 OFLOXACIN 200MG FC TAB 1 3 2     87 2009 OFLOXACIN 300MG FC TAB 1 3 2     88 2751 OLANZAPINE 2.5MG TAB 1 2 1     89 1907 OLANZAPINE 5MG TAB 1 4 6     90 2746 OLANZAPINE 15MG TAB 1 2 1     91 931 OMEPRAZOLE 20MG CAP 5 4 14     92 2283 ORLISTATE 120MG CAP 1 3 2     93 933 ORS 27G SACHET 1 4 6     94 966 PENICILLIN V POTASSIUM 500MG (800000 U) TAB 1 3 2     95 2332 PANTOPRAZOL 20MG TAB 5 3 2     96 2333 PANTOPRAZOL 40MG TAB 5 3 3     97 1354 PETHIDINE HCL 50MG/1ML AMP 1 1 0 1   98 1355 PETHIDINE HCL 50MG/ML 2ML AMP 1 1 0 1   99 5624 PIOGLITAZONE 15MG TAB 2 3 3     100 5217 PIOGLJTAZONE 30MG TAB 5 3 3     101 5625 PIOGLITAZONE 45MG TAB 1 3 2     102 980 PHENOBARBITAL 15MG TAB 1 3 2     103 1012 PIPERAZINE CITRATE 583.5MG/5ML SYRUP 1 3 3     104 1035 POVIDONE IODINE 10% 250ML 1 4 8     105 1040 POVIDONE IODINE 10% 60ML 1 4 9     106 1034 POVIDONE IODINE 10% 1L 1 4 7     107 1060 PROMETHAZINE 113MG/100ML 60ML SYRUP 1 4 5     108 1653 PROPOFOL 200MG/20ML VIAL 1 1 0 5   109 1951 PROPOFOL 500MG/50ML VIAL 1 1 0 4   110 1926 RALOXIFENE 60MG TAB 1 3 2 1   111 1093 RANITIDINE 150MG TAB 1 4 12     112 4903 REPAGLINIDE 0.5MG TAB 2 1 0 1   113 4904 REPAGLINIDE 1MG TAB 2 1 0 1   114 4905 REPAGLINIDE 2MG TAB 2 2 1 1   115 1902 RIVASTIGMINE 1.5MG TAB 4 3 3 1   116 1903 RIVASTIGMINE 3MG TAB 2 3 3 1   117 1897 SERTRALIN HCL 100MG TAB 1 4 9 1   118 1673 SIMVASTATIN 20MG TAB 2 4 8     119 2458 SIMVASTATIN 10MG TAB 1 4 5     120 9802 SODIUM HYALURONATE 0.15% 10ML OPH DROP 1 1 0 0   121 7259 SODIUM CHLORIDE 0.65% 20ML NASAL SPRAY 1 3 2     122 2004 SUMATRIPTAN SUCCINATE 50MG FC TAB 1 4 10 1   123 4963 SUMATRIPTAN 6MG/1ML AMP 1 2 1     124 2005 SUMATRIPTAN SUCCINATE 100MG FC TAB 1 4 5 1   125 1164 SOTALOL HCL 80MG TAB 3 3 2 2   126 1163 SOTALOL HCL 40MG TAB 1 3 2     127 6975 TADALAFIL 20MG TAB 1 3 6 1   128 5100 TAMSULOSIN 0.4MG CAP 3 3 1 1   129 1201 TESTOSTRONE ENANTATE 250MG/1ML AMP 1 2 1     130 1200 TESTOSTRONE ENANTATE 100MG/1ML AMP 1 2 1     131 1883 TOPIRAMATE 100MG TAB 1 3 3     132 2103 TRAMADOL HCL 100MG TAB 6 4 13 1   133 1258 TRIHEXYPHENIDYL HCL 2MG TAB 1 3 3     134 9801 VALSARTAN 40MG TAB 2 1 0 0   7095 VALSARTAN 40MG CAP   135 5423 VALSARTAN 80MG TAB 2 3 3     5560 VALSARTAN 80MG CAP 136 5766 VALSARTAN 160MG TAB 2 3 3     5561 VALSARTAN 160MG CAP   137 1287 VITAMINE A 25000 U TAB 1 3 3     1372 VITAMINE A 25000 U PEARL   138 1316 ZINC OXIDE 20% 30G OINT 1 3 2     139 7253 ZOLPIDEM 5MG TAB 2 3 4     140 6028 ZOLPIDEM 10MG TAB 2 3 4 1

Iran Sets Punishment for Errant Exporters

Nourlaw.com,19 December 2007 -- According to a joint announcement of the Central Bank of the Islamic Republic of Iran (CBI) and the Export Development Bank of Iran (EDBI) issued on 21/09/1386 (12 December 2007), the member ministers of the Economy Commission in their session of 07/08/1386 (29 October 2007) resolved that:EDBI is obliged to provide the CBI the list of the persons who have not settled their export foreign currency revolving fund in due time for being relieved from all or parts of the following restrictions against them in proportion to the amount of the debts of the said persons on the basis of CBI's legal authority such as the Law Prohibiting Exit of Bank Debtors approved by the Revolution Council on 20/02/1359 (10/05/1980) and implemented through the banking network against the said debtors:A)   Non-extension of any new facilities in rial or in foreign currency to them by governmental or private banks;B) Non-issuance of good conduct certification which they may require for presenting to the related authorities;C)   Banning them from exiting the country. The said decree was ratified by President Mahmoud Ahmadinejad, on 19/09/1386 (10 December 2007).The foreign currency revolving fund is a monetary facility made available to persons who produce goods designed for export.

12 December 2007

Import of Livestock Permitted

Nourlaw.com,12 December 2007 -- The Directorate General of Export and Import Regulations has announced in its circular letter Number 210/2082 dated 06/09/1386 that: "Hereby by virtue of the powers resulting from Part 9 of Article 28 of the Export and Import Implementation Regulations, registration of orders and import of livestock by utilizing free market foreign currency and with observance of other related regulations is allowed".

5 December 2007

Accession of Iran to Patent Cooperation Treaty (PCT)

Nourlaw.com, 6 December 2007-- Iranian parliament approved on 24/7/1386 (16 October 2007) the Islamic Republic of Iran becoming signatory to the Patent Cooperation Treaty (PCT) which enables inventors to register their patents in PCT member countries simply by filing a single application with the related national registration authority. The legislation was published on 11 November 2007 in the Official Gazette and has been in effect from 27 November 2007. The Treaty last modified on 3 October 2001, is designed to be an instrument for the progress of science and technology through bolstering and improving the legal protection of inventions. It is intended to simplify and render more economical procurement of protection for inventions where protection is sought in several countries. The Treaty facilitates and accelerates public access to the technical information contained in documents describing new inventions, thereby fostering and increasing the pace of economic growth in developing countries through the adoption of measures designed to upgrade the efficiency of their legal systems, whether national or regional. It promotes protection for inventions by providing easily accessible information on the availability of applicable technological solutions to special needs and by facilitating access to the ever expanding volume of modern technology.PCT stipulates that no provision of the Treaty shall be interpreted as diminishing the rights under the Paris Convention for the Protection of Industrial Property (Paris Convention) of any national or resident of any country party to that Convention. Iran is a member of the Paris Convention.By virtue of Article 3 of PCT, Applications for the protection of inventions in any of the Contracting States may be filed as an international application under this Treaty. An international application shall contain, as specified in this Treaty and the Regulations, a request, a description, one or more claims, one or more drawings (where required), and an abstract. The abstract merely serves the purpose of technical information and cannot be taken into account for any other purpose, particularly not for the purpose of interpreting the scope of the